Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disorders.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

DNA-PK inhibition enhances gene editing efficiency in HSPCs for CRISPR-based treatment of X-linked hyper IgM syndrome.

Molecular therapy. Methods & clinical development·2025
Same author

Targeting human plasma cells using regulated BCMA CAR T cells eliminates circulating antibodies in humanized mice.

Molecular therapy : the journal of the American Society of Gene Therapy·2024
Same author

Efficient and sustained <i>FOXP3</i> locus editing in hematopoietic stem cells as a therapeutic approach for IPEX syndrome.

Molecular therapy. Methods & clinical development·2024
Same author

Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo.

Nature communications·2022
Same author

Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1.

Human gene therapy·2022

Related Experiment Video

Updated: Jun 3, 2026

Transfection, Selection, and Colony-picking of Human Induced Pluripotent Stem Cells TALEN-targeted with a GFP Gene into the AAVS1 Safe Harbor
07:28

Transfection, Selection, and Colony-picking of Human Induced Pluripotent Stem Cells TALEN-targeted with a GFP Gene into the AAVS1 Safe Harbor

Published on: February 1, 2015

AAV-mediated gene targeting methods for human cells.

Iram F Khan1, Roli K Hirata, David W Russell

  • 1Department of Medicine, University of Washington, Seattle, WA, USA.

Nature Protocols
|April 2, 2011
PubMed
Summary
This summary is machine-generated.

Adeno-associated virus (AAV) vectors enable efficient gene targeting in human cells, achieving higher frequencies than conventional methods. This protocol details AAV vector design and application for precise genetic modification.

More Related Videos

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Related Experiment Videos

Last Updated: Jun 3, 2026

Transfection, Selection, and Colony-picking of Human Induced Pluripotent Stem Cells TALEN-targeted with a GFP Gene into the AAVS1 Safe Harbor
07:28

Transfection, Selection, and Colony-picking of Human Induced Pluripotent Stem Cells TALEN-targeted with a GFP Gene into the AAVS1 Safe Harbor

Published on: February 1, 2015

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Cell Biology

Background:

  • Gene targeting is crucial for genetic research and therapeutic development.
  • Traditional methods like transfection and electroporation yield low gene targeting frequencies.
  • Adeno-associated virus (AAV) vectors offer a promising alternative for precise gene modification.

Purpose of the Study:

  • To provide a detailed protocol for efficient gene targeting in human cells using AAV vectors.
  • To optimize AAV vector design, preparation, and transduction for various human cell types.
  • To establish a reliable method for identifying successfully targeted clones.

Main Methods:

  • Development of AAV vectors for gene targeting.
  • Preparation and titration of AAV vector stocks.
  • Optimization of transduction protocols for human pluripotent stem cells, mesenchymal stem cells, fibroblasts, and cell lines.
  • Southern blot analysis for identification of targeted clones.

Main Results:

  • Achieved gene targeting frequencies of 10(-5) to 10(-2) per infected cell, significantly higher than conventional methods.
  • Demonstrated the introduction of diverse mutations into chromosomal loci with high fidelity and no genotoxicity.
  • Successfully applied the protocol across multiple human cell types, including stem cells and fibroblasts.

Conclusions:

  • AAV vectors provide a highly efficient and precise method for gene targeting in human cells.
  • The detailed protocol facilitates reproducible gene modification for research and potential therapeutic applications.
  • The described methodology offers a robust platform for genetic engineering in various human cell contexts.